• 1
    Moyzis RK, Buckingham JM, Cram LS, Dani M, Deaven LL, Jones MD, Meyne J, Ratliff RL & Wu JRA (1988) Highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. Proc Natl Acad Sci USA 85, 66226626.
  • 2
    Blackburn EH (2001) Switching and signaling at the telomere. Cell 106, 661673.
  • 3
    Stewart SA & Weinberg RA (2006) Telomeres: cancer to human aging. Annu Rev Cell Dev Biol 22, 531557.
  • 4
    d’Adda di Fagagna F, Teo SH & Jackson SP (2004) Functional links between telomeres and proteins of the DNA-damage response. Genes Dev 18, 17811799.
  • 5
    Wright WE, Tesmer VM, Huffman KE, Levene SD & Shay JW (1977) Normal human chromosomes have long G-rich telomeric overhangs at one end. Genes Dev 11, 28012809.
  • 6
    Zaug AJ, Podell ER & Cech TR (2005) Human POT1 disrupts telomeric G-quadruplexes allowing telomerase extension in vitro. Proc Natl Acad Sci USA 102, 1086410869.
  • 7
    Denchi EL & de Lange T (2007) Protection of telomeres through independent control of ATM and ATR by TRF2 and POT1. Nature 448, 10681071.
  • 8
    Miyoshi T, Kanoh J, Saito M & Ishikawa F (2008) Fission yeast Pot1–Tpp1 protects telomeres and regulates telomere length. Science 320, 13411344.
  • 9
    Gomez D, O’Donohue MF, Wenner T, Douarre C, Macadre J, Koebel P, Giraud-Panis MJ, Kaplan H, Kolkes A, Shin-Ya K et al. (2006) The G-quadruplex ligand telomestatin inhibits POT1 binding to telomeric sequences in vitro and induces GFP–POT1 dissociation from telomeres in human cells. Cancer Res 66, 69086912.
  • 10
    Gomez D, Wenner T, Brassart B, Douarre C, O’Donohue MF, El KV, Shin-Ya K, Morjani H, Trentesaux C & Riou J-F (2006) Telomestatin-induced telomere uncapping is modulated by POT1 through G-overhang extension in HT1080 human tumor cells. J Biol Chem 281, 3872138729.
  • 11
    Gunaratnam M, Greciano O, Martins C, Reszka AP, Schultes CM, Morjani H, Riou JF & Neidle S (2007) Mechanism of acridine-based telomerase inhibition and telomere shortening. Biochem Pharmacol 74, 679689.
  • 12
    d’Adda di Fagagna F & Reaper PM (2003) A DNA damage checkpoint response in telomere-initiated senescence. Nature 426, 194198.
  • 13
    Soldatenkov VA, Vetcher AA, Duka T & Ladame S (2008) First evidence of a functional interaction between DNA quadruplexes and poly(ADP-ribose) polymerase-1. ACS Chem Biol 3, 214219.
  • 14
    Paeschke K, Juranek S, Simonsson T, Hempel A, Rhodes D & Lipps HJ (2008) Telomerase recruitment by the telomere end binding protein-β facilitates G-quadruplex DNA unfolding in ciliates. Nat Struct Mol Biol 15, 598604.
  • 15
    Lipps HJ & Rhodes D (2009) G-quadruplex structures: in vivo evidence and function. Trends Cell Biol 19, 414422.
  • 16
    Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL & Shay JW (1994) Specific association of human telomerase activity with immortal cells and cancer. Science 266, 20112015.
  • 17
    Shay JW & Wright WE (2006) Telomerase therapeutics for cancer: challenges and new directions. Nat Rev Drug Discov 5, 577584.
  • 18
    de Cian A, Lacroix L, Douarre C, Temime-Smaali N, Trentesaux C, Riou J-F & Mergny J-L (2008) Targeting telomeres and telomerase. Biochimie 90, 131155.
  • 19
    Zahler AM, Williamson JR, Cech TR & Prescott DM (1991) Inhibition of telomerase by G-quartet DNA structures. Nature 350, 718720.
  • 20
    Sun D, Thompson B, Cathers BE, Salazar M, Kerwin SM, Trent JO, Jenkins TC, Neidle S & Hurley LH (1997) Inhibition of human telomerase by a G-quadruplex-interactive compound. J Med Chem 40, 21132116.
  • 21
    Monchaud D & Teulade-Fichou MP (2008) A hitchhiker’s guide to G-quadruplex ligands. Org Biomol Chem 6, 627636.
  • 22
    Ou T, Lu Y, Tan J, Huang Z, Wong K & Gu L (2008) G-quadruplexes: targets in anticancer drug design. ChemMedChem 3, 690713.
  • 23
    De Cian A, Cristofari G, Reichenbach P, De Lemos E, Monchaud D, Teulade-Fichou MP, Shin-Ya K, Lacroix L, Lingner J & Mergny JL (2007) Re-evaluation of telomerase inhibition by quadruplex ligands and their mechanisms of action. Proc Natl Acad Sci USA 104, 1734717352.
  • 24
    Reed J, Gunaratnam M, Beltran M, Reszka AP, Vilar R & Neidle S (2008) TRAP-LIG, a modified telomere repeat amplification protocol assay to quantitate telomerase inhibition by small molecules. Anal Biochem 380, 99105.
  • 25
    Kim MY, Vankayalapati H, Shin-Ya K, Wierzba K & Hurley LH (2002) Telomestatin, a potent telomerase inhibitor that interacts quite specifically with the human telomeric intramolecular G-quadruplex. J Am Chem Soc 124, 20982099.
  • 26
    Moorhouse AD, Santos AM, Gunaratnam M, Moore M, Neidle S & Moses JE (2006) Stabilization of G-quadruplex DNA by highly selective ligands via click chemistry. J Am Chem Soc 128, 1597215973.
  • 27
    Drewe WC, Nanjunda R, Gunaratnam M, Beltran M, Parkinson GN, Reszka AP, Wilson WD & Neidle S (2008) Rational design of substituted diarylureas: a scaffold for binding to G-quadruplex motifs. J Med Chem 51, 77517767.
  • 28
    Rahman KM, Reszka AP, Gunaratnam M, Haider SM, Howard PW, Fox KR, Neidle S & Thurston DE (2009) Biaryl polyamides as a new class of DNA quadruplex-binding ligands. Chem Commun 40974099.
  • 29
    Dash J, Shirude PS & Balasubramanian S (2008) G-quadruplex recognition by bis-indole carboxamides. Chem Commun 30553057.
  • 30
    Kelland LR (2007) Targeting the limitless replicative potential of cancer: the telomerase/telomere pathway. Clin Cancer Res 13, 49604963.
  • 31
    Oganesian L & Bryan TM (2007) Physiological relevance of telomeric G-quadruplex formation: a potential drug target. BioEssays 29, 155165.
  • 32
    Burger AM, Dai F, Schultes CM, Reszka AP, Moore MJ, Double JA & Neidle S (2005) The G-quadruplex-interactive molecule BRACO-19 inhibits tumor growth, consistent with telomere targeting and interference with telomerase function. Cancer Res 65, 14891496.
  • 33
    Phatak P, Cookson JC, Dai F, Smith V, Gartenhaus RB, Stevens MF & Burger AM (2007) Telomere uncapping by the G-quadruplex ligand RHPS4 inhibits clonogenic tumour cell growth in vitro and in vivo consistent with a cancer stem cell targeting mechanism. Br J Cancer 96, 12231233.
  • 34
    Tauchi T, Shin-Ya K, Sashida G, Sumi M, Nakajima A, Shimamoto T, Ohyashiki JH & Ohyashiki K (2003) Activity of a novel G-quadruplex-interactive telomerase inhibitor, telomestatin (SOT-095), against human leukemia cells: involvement of ATM-dependent DNA damage response pathways. Oncogene 22, 53385347.
  • 35
    Salvati E, Leonetti C, Rizzo A, Scarsella M, Mottolese M, Galati R, Sperduti I, Stevens MF, D’Incalci M, Blasco M et al. (2007) Telomere damage induced by the G-quadruplex ligand RHPS4 has an antitumor effect. J Clin Invest 117, 32363247.
  • 36
    Rodriquez R, Müller S, Yeoman JA, Trentesaux C, Riou J-F & Balasubramanian S (2008) A novel small molecule that alters shelterin integrity and triggers a DNA-damage response at telomeres. J Am Chem Soc 130, 1575815759.
  • 37
    Incles CM, Schultes CM, Kempski H, Koehler H, Kelland LR & Neidle S (2004) A G-quadruplex telomere targeting agent produces p16-associated senescence and chromosomal fusions in human prostate cancer cells. Mol Cancer Ther 3, 12011206.
  • 38
    Hemann MT, Strong MA, Hao LY & Greider CW (2001) The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability. Cell 107, 6777.
  • 39
    Londoño-Vallejo JA (2008) Telomere instability and cancer. Biochimie 90, 7382.
  • 40
    Arnoult N, Shin-Ya K & Londoño-Vallejo JA (2008) Studying telomere replication by Q-CO-FISH: the effect of telomestatin, a potent G-quadruplex ligand. Cytogenet Genome Res 122, 229236.
  • 41
    Tauchi T, Shin-ya K, Sashida G, Sumi M, Okabe S, Ohyashiki JH & Ohyashiki K (2006) Telomerase inhibition with a novel G-quadruplex-interactive agent, telomestatin: in vitro and in vivo studies in acute leukemia. Oncogene 25, 57195725.
  • 42
    Fedoroff OY, Salazar M, Han H, Chemeris VV, Kerwin SM & Hurley LH (1998) NMR-based model of a telomerase-inhibiting compound bound to G-quadruplex DNA. Biochemistry 37, 1236712374.
  • 43
    Haider SM, Parkinson GN & Neidle S (2003) Structure of a G-quadruplex–ligand complex. J Mol Biol 326, 117125.
  • 44
    Gavathiotis E, Heald RA, Stevens MF & Searle MS (2003) Drug recognition and stabilisation of the parallel-stranded DNA quadruplex d(TTAGGGT)4 containing the human telomeric repeat. J Mol Biol 334, 2536.
  • 45
    Campbell NH, Parkinson GN, Reszka AP & Neidle S (2008) Structural basis of DNA quadruplex recognition by an acridine drug. J Am Chem Soc 130, 67226724.
  • 46
    Parkinson GN, Cuenca F & Neidle S (2008) Topology conservation and loop flexibility in quadruplex–drug recognition: crystal structures of inter- and intramolecular telomeric DNA quadruplex–drug complexes. J Mol Biol 381, 11451156.
  • 47
    Campbell NH, Patel M, Tofa AB, Ghosh R, Parkinson GN & Neidle S (2009) Selectivity in ligand recognition of G-quadruplex loops. Biochemistry 48, 16751680.
  • 48
    Huppert JL & Balasubramanian S (2007) G-quadruplexes in promoters throughout the human genome. Nucleic Acids Res 35, 406413.
  • 49
    Todd AK, Johnston M & Neidle S (2005) Highly prevalent putative quadruplex sequence motifs in human DNA. Nucleic Acids Res 33, 29012907.
  • 50
    Huppert JL & Balasubramanian S (2005) Prevalence of quadruplex sequences in the human genome. Nucleic Acids Res 33, 29082916.
  • 51
    Verma A, Halder K, Halder R, Yadav VK, Rawal P, Thakur RK, Mohd F, Sharma A & Chowdhury S (2008) Genome-wide computational and expression analyses reveal G-quadruplex DNA motifs as conserved cis-regulatory elements in human and related species. J Med Chem 51, 56415649.
  • 52
    Siddiqui-Jain A, Grand CL, Bearss DJ & Hurley LH (2002) Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription. Proc Natl Acad Sci USA 99, 1159311598.
  • 53
    Qin Y & Hurley LH (2008) Structures, folding patterns, and functions of intramolecular DNA G-quadruplexes found in eukaryotic promoter regions. Biochimie 90, 11491171.
  • 54
    Gowan SM, Harrison JR, Patterson L, Valenti M, Read MA, Neidle S & Kelland LR (2002) A G-quadruplex-interactive potent small-molecule inhibitor of telomerase exhibiting in vitro and in vivo antitumor activity. Mol Pharmacol 61, 11541162.
  • 55
    Martins C, Gunaratnam M, Stuart J, Makwana V, Greciano O, Reszka AP, Kelland LR & Neidle S (2007) Structure-based design of benzylamino-acridine compounds as G-quadruplex DNA telomere targeting agents. Bioorg Med Chem Lett 17, 22932298.
  • 56
    Leonetti C, Scarsella M, Riggio G, Rizzo A, Salvati E, D’Incalci M, Staszewsky L, Frapolli R, Stevens MF, Stoppacciaro A et al. (2008) G-quadruplex ligand RHPS4 potentiates the antitumor activity of camptothecins in preclinical models of solid tumors. Clin Cancer Res 14, 72847291.
  • 57
    Grand CL, Han H, Munoz RM, Weitman S, Von Hoff DD, Hurley LH & Bearss DJ (2002) The cationic porphyrin TMPyP4 down-regulates c-myc and human telomerase reverse transcriptase expression and inhibits tumor growth in vivo. Mol Cancer Ther 1, 565573.
  • 58
    Drygin D, Siddiqui-Jain A, O’Brien S, Schwaebe M, Lin A, Bliesath J, Ho CB, Proffitt C, Trent K, Whitten JP et al. (2009) Anticancer activity of CX-3543: a direct inhibitor of rRNA biogenesis. Cancer Res, doi:10.1158/0008-5472.CAN-09-1304.
  • 59
    Gunaratnam M, Green C, Moreira JB, Moorhouse AD, Kelland LR, Moses JE & Neidle S (2009) G-quadruplex compounds and cis-platin act synergistically to inhibit cancer cell growth in vitro and in vivo. Biochem Pharmacol 78, 115122.
  • 60
    Gunaratnam M, Swank S, Haider SM, Galesa K, Reszka AP, Beltran M, Cuenca F, Fletcher JA & Neidle S (2009) Targeting human gastrointestinal stromal tumor cells with a quadruplex-binding small molecule. J Med Chem 52, 37743783.